The genomics of cardiovascular disorders: therapeutic implications.
about
Pharmacogenomics and acquired long QT syndrome.Characteristics and prognostic importance of myocardial fibrosis in patients with dilated cardiomyopathy assessed by contrast-enhanced cardiac magnetic resonance imaging.Genetic polymorphisms of the beta-adrenergic system: association with essential hypertension and response to beta-blockade.
P2860
The genomics of cardiovascular disorders: therapeutic implications.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The genomics of cardiovascular disorders: therapeutic implications.
@ast
The genomics of cardiovascular disorders: therapeutic implications.
@en
type
label
The genomics of cardiovascular disorders: therapeutic implications.
@ast
The genomics of cardiovascular disorders: therapeutic implications.
@en
prefLabel
The genomics of cardiovascular disorders: therapeutic implications.
@ast
The genomics of cardiovascular disorders: therapeutic implications.
@en
P2860
P1433
P1476
The genomics of cardiovascular disorders: therapeutic implications.
@en
P2093
P2860
P304
P356
10.2165/00003495-200059050-00001
P577
2000-05-01T00:00:00Z
P6179
1000037406